Showing results (111-120 of 382) with videos related to

Sort By:
Pageof 39
Cell Systems|July 2, 2018
IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to ImmunotherapyJames C Chen, Rolando Perez-Lorenzo, Yvonne M Saenger, et al.
Current Urology Reports|February 14, 2015
Tissue-engineered urinary conduitsMax Kates, Anirudha Singh, Hotaka Matsui, et al.
World Journal of Urology|January 24, 2019
Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytologyMohit Gupta, Niv Milbar, Giorgia Tema, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?Charlene M Fares, Eliezer M Van Allen, Charles G Drake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive TrialsMax Kates, Andres Matoso, Woonyoung Choi, et al.
Cancer Cytopathology|October 9, 2023
Urinary IL-6 and IL-8 as predictive markers in bladder urothelial carcinoma: A pilot studyChristopher J VandenBussche, Christopher D Heaney, Max Kates, et al.
Pageof 39